29 citations
,
September 2023 in “Journal of Clinical Medicine” This study found that semaglutide significantly reduced body weight in almost 80% of obese PCOS patients unresponsive to lifestyle changes, often normalizing menstrual cycles with few side effects.
August 2022 in “Journal of Education Health and Sport” This article discusses the prevalence and impact of polycystic ovary syndrome on reproductive-aged women and reports no new clinical findings.
1 citations
,
November 2022 in “Journal of the Endocrine Society” This study found that US adults with classic congenital adrenal hyperplasia most preferred a hypothetical adjunctive therapy that prevents glucocorticoid-induced weight gain over other potential benefits.
3 citations
,
June 2019 in “Clinical nursing studies” In this study, the researchers reported that polycystic ovary syndrome negatively impacts the quality of life for women due to associated phenotypic characteristics like obesity and hirsutism.
1 citations
,
July 2024 in “Quality in Sport” This review discusses the impact of lifestyle interventions on managing polycystic ovary syndrome and concludes that such modifications can significantly improve clinical outcomes and the health profile of patients, but reports no new results.